Contact us for free information or to start a free case review.
March 10, 2005
The FDA has issued a public health advisory to inform healthcare providers and patients of potential cancer risks from two popular eczema creams. Based on animal studies, case reports in a small number of patients and how the drugs work, the FDA said both Protopic and Elidel might carry a risk of cancer.
Although more studies are needed to determine the actual cancer risk present among human Protopic or Elidel users, the FDA has recommended the products be used only as second-line agents for short-term and intermittent treatment of eczema in patients unresponsive or intolerant of other treatments.
In addition, the drug agency has advised Protopic and Elidel never to be used in children younger than two years of age because the drugs’ effects on developing immune systems in infants and children is not known.
Approved in December 2000, the FDA has received reports of lymphoma and skin cancer in children and adults treated with Protopic, though the link between the product and reported cancers has not been clearly established. Protopic is applied to the skin to control eczema by suppressing the immune system.
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.